Last Close
Mar 19  •  04:00PM ET
25.89
Dollar change
+0.42
Percentage change
1.65
%
Mar 18, 11:05 PMHeartflow beats Q4 estimates, issues 2026 revenue and plaque guidance, raises midterm non-GAAP gross margin target to 85%
IndexRUT P/E- EPS (ttm)-1.40 Insider Own36.91% Shs Outstand85.28M Perf Week24.53%
Market Cap2.20B Forward P/E- EPS next Y-0.35 Insider Trans-6.20% Shs Float53.72M Perf Month9.33%
Enterprise Value2.05B PEG- EPS next Q-0.19 Inst Own56.51% Short Float10.15% Perf Quarter-2.19%
Income-116.79M P/S- EPS this Y65.23% Inst Trans17.53% Short Ratio3.90 Perf Half Y-18.48%
Sales- P/B7.34 EPS next Y38.46% ROA- Short Interest5.45M Perf YTD-11.18%
Book/sh3.53 P/C12.47 EPS next 5Y- ROE- 52W High41.22 -37.20% Perf Year-
Cash/sh2.08 P/FCF- EPS past 3/5Y5.20% - ROIC-36.87% 52W Low20.13 28.61% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y42.10% - Gross Margin- Volatility10.86% 8.01% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)2.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.04 Sales Y/Y TTM- Profit Margin- RSI (14)56.21 Recom1.33
Dividend Gr. 3/5Y- - Current Ratio5.04 EPS Q/Q-10.93% SMA2011.57% Beta- Target Price37.67
Payout- Debt/Eq0.07 Sales Q/Q83.03% SMA50-4.71% Rel Volume2.81 Prev Close25.47
Employees843 LT Debt/Eq0.05 EarningsMar 18 AMC SMA200-15.15% Avg Volume1.40M Price25.89
IPOAug 08, 2025 Option/ShortYes / Yes EPS/Sales Surpr.29.04% 5.48% Trades Volume3,929,851 Change1.65%
Date Action Analyst Rating Change Price Target Change
Jan-28-26Initiated Wells Fargo Overweight $38
Sep-02-25Initiated Stifel Buy $35
Sep-02-25Initiated Piper Sandler Overweight $38
Sep-02-25Initiated Morgan Stanley Equal-Weight $35
Sep-02-25Initiated JP Morgan Overweight $36
Sep-02-25Initiated Canaccord Genuity Buy $35
Mar-18-26 11:00PM
04:22PM
04:01PM
Mar-17-26 09:18AM
Mar-16-26 08:00AM
01:26AM Loading…
Feb-25-26 01:26AM
Feb-18-26 04:05PM
Feb-13-26 04:21PM
Feb-12-26 08:00AM
Jan-29-26 09:41AM
Jan-28-26 09:39AM
Jan-06-26 08:00AM
Jan-05-26 04:05PM
Dec-23-25 11:53PM
Dec-18-25 07:42PM
04:05PM Loading…
04:05PM
Dec-12-25 09:49AM
Dec-11-25 03:10AM
Nov-19-25 04:33PM
Nov-12-25 04:22PM
04:01PM
Nov-09-25 01:30PM
Nov-04-25 07:06AM
Nov-03-25 08:00AM
Oct-23-25 04:05PM
Oct-22-25 08:00AM
Sep-29-25 08:07AM
Sep-23-25 06:55PM
Sep-22-25 04:05PM
Sep-19-25 05:28PM
01:00AM Loading…
Sep-11-25 01:00AM
Sep-06-25 06:35AM
Sep-04-25 10:20AM
Sep-03-25 04:54PM
04:54PM
09:16AM
Sep-02-25 09:45AM
Aug-27-25 04:24PM
Aug-18-25 01:16PM
Aug-11-25 04:30PM
Aug-09-25 09:53AM
Aug-08-25 01:40PM
Jul-22-25 06:28PM
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rogers CampbellOfficerMar 19 '26Proposed Sale25.6964,5331,658,030Mar 19 04:23 PM
Farquhar John C.M.OfficerMar 18 '26Proposed Sale25.009,725243,125Mar 18 02:17 PM
BARABE TIMOTHY CDirectorMar 11 '26Option Exercise2.228,66719,241179,521Mar 12 07:57 PM
Farquhar John C.M.Chief Executive OfficerMar 10 '26Sale22.6612,837290,886581,450Mar 12 07:55 PM
Farquhar John C.M.OfficerMar 10 '26Proposed Sale22.6612,837290,886Mar 10 10:53 AM
Cullivan Julie ADirectorMar 05 '26Sale25.009,122228,05027,291Mar 06 08:18 PM
Cullivan Julie ADirectorMar 05 '26Proposed Sale25.009,122228,050Mar 05 02:11 PM
BARABE TIMOTHY CDirectorFeb 17 '26Option Exercise8.332,49720,800170,854Feb 19 07:14 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Option Exercise5.8467,016391,398141,187Feb 17 08:07 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Sale24.4965,1531,595,48676,034Feb 17 08:07 PM
Rogers CampbellOfficerFeb 12 '26Proposed Sale24.4965,1531,595,485Feb 12 04:45 PM
Farquhar John C.M.Chief Executive OfficerFeb 10 '26Sale27.4622,562619,553591,656Feb 10 08:24 PM
Farquhar John C.M.OfficerFeb 10 '26Proposed Sale27.4622,562619,557Feb 10 04:12 PM
Cullivan Julie ADirectorFeb 05 '26Sale27.328,000218,56036,413Feb 06 09:42 PM
Bain Capital Life Sciences Inv10% OwnerFeb 04 '26Sale28.052,000,00056,100,00010,448,158Feb 06 04:58 PM
Cullivan Julie ADirectorFeb 05 '26Proposed Sale27.328,000218,560Feb 05 09:58 AM
Lightcap Jeffrey CDirectorDec 16 '25Buy26.3440,0001,053,68040,000Dec 17 06:43 PM